- Home
- EML vs AMRN Comparison
EML vs AMRN Comparison
Compare EML & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EML
- AMRN
- Stock Information
- Founded
- EML 1858
- AMRN 1989
- Country
- EML United States
- AMRN Ireland
- Employees
- EML N/A
- AMRN N/A
- Industry
- EML Industrial Machinery/Components
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- EML Consumer Discretionary
- AMRN Health Care
- Exchange
- EML Nasdaq
- AMRN Nasdaq
- Market Cap
- EML 141.7M
- AMRN 216.0M
- IPO Year
- EML N/A
- AMRN 1993
- Fundamental
- Price
- EML $23.29
- AMRN $16.51
- Analyst Decision
- EML
- AMRN Strong Sell
- Analyst Count
- EML 0
- AMRN 1
- Target Price
- EML N/A
- AMRN $12.00
- AVG Volume (30 Days)
- EML 12.1K
- AMRN 180.2K
- Earning Date
- EML 08-05-2025
- AMRN 07-30-2025
- Dividend Yield
- EML 1.89%
- AMRN N/A
- EPS Growth
- EML N/A
- AMRN N/A
- EPS
- EML N/A
- AMRN N/A
- Revenue
- EML $271,440,503.00
- AMRN $214,112,000.00
- Revenue This Year
- EML $1.56
- AMRN N/A
- Revenue Next Year
- EML $7.00
- AMRN $7.88
- P/E Ratio
- EML $11.13
- AMRN N/A
- Revenue Growth
- EML 8.15
- AMRN N/A
- 52 Week Low
- EML $19.06
- AMRN $7.08
- 52 Week High
- EML $35.03
- AMRN $17.18
- Technical
- Relative Strength Index (RSI)
- EML 49.74
- AMRN 71.62
- Support Level
- EML $22.72
- AMRN $12.30
- Resistance Level
- EML $23.39
- AMRN $17.18
- Average True Range (ATR)
- EML 0.49
- AMRN 1.09
- MACD
- EML -0.05
- AMRN 0.26
- Stochastic Oscillator
- EML 48.32
- AMRN 73.61
About EML Eastern Company (The)
The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to industrial markets. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It operates in the United States and Other Countries and generates the majority of its revenue from the United States.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.